Clinical Trials: Phase II Trial of Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Share this article:

Sponsor and Collaborators

Memorial Sloan-Kettering Cancer Center

Bayer

Contact

David D'Adamo, MD, PhD

212-639-7573 

Mary Louise Keohan, MD

212-639-2809 

Principal Investigator

David D'Adamo, MD, PhD, Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier

NCT00837148

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs